#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Increase in RNASEL gene expression by miR-29-3p inhibitors in HEK293T cells


Autoři: A. Maleki 1;  M. Ravanshad 1;  F. Kouhkan 2
Působiště autorů: Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran 1;  Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, Tehran, Iran 2
Vyšlo v časopise: Epidemiol. Mikrobiol. Imunol. 69, 2020, č. 3, s. 116-120
Kategorie: Původní práce

Souhrn

Background: RNase L is known as a terminal component of antiviral and Interferon (IFN) pathways in mammalian cells. On the other hand, the human miR-29 family of microRNAs (miRs) has three mature members, miR-29a, miR-29b, and miR-29c. miR-29 is encoded by two gene clusters and the family members have multifunctional roles in various biological processes.

Objectives: To determine the potential role of miR-29 in the regulation of RNASEL gene expression by designing inhibitors against its targeting miRNA, miR-29a-3p and evaluate the RNase L expression.

Material and Methods: After selecting miR-29a-3p as a main regulating miRNA for RNASEL in silico, two inhibitors were designed against it and synthesized. Synthesized strands were made double-stranded DNA oligos, treated with T4 polynucleotide kinase (PNK), cloned into the pCDH-CMV-MCS-EF1-cGFP-T2A-Puro vector and transformed into DH5α. Colony PCR and sequencing was done for affirmation. Then the miR-29a-3p inhibitors were transfected into HEK-293T cell line and RNASEL gene expression was analyzed.

Results: The miR-29a-3p inhibitors decreased miR-29a-3p expression in vitro. In addition, miR-29a-3p expression reduction resulted in an increase of RNASEL gene expression.

Conclusions: miR-29a-3p inhibitors could increase in RNASEL gene expression which potentially affects the antiviral/IFN pathway. The inhibitors could be considered as drug candidates in different diseases especially viral infections.

Klíčová slova:

Anti-mir – mir-29a-3p – real-Time pcr – rnase l


Zdroje

1. Lee HJ. Exceptional stories of microRNAs. Experimental Biology and Medicine, 2013;238(4):339–343.

2. Kim VN, Nam JW. Genomics of microRNA. Trends in Genetics, 2006;22(3):165–173.

3. Lin SL, Kim H, Ying SY. Intron-mediated RNA interference and microRNA (miRNA). Front Biosci, 2008;13 : 2216–2230.

4. Suzuki HI, Miyazono K. Emerging complexity of microRNA genera-tion cascades. Journal of biochemistry. 2011;149(1):15–25.

5. Hwang HW, Wentzel EA, Mendell JT. A hexanucleotide element directs microRNA nuclear import. Science, 2007;315(5808):97–100.

6. Ouyang YB, Xu L, Yue S, Liu S, Giffard RG. Neuroprotection by astrocytes in brain ischemia: importance of microRNAs. Neuroscience letters, 2014;565 : 53–58.

7. Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M. MicroRNA are Central Players in Anti -⁠ and Profibrotic Gene Regulation during Liver Fibrosis. Front Physiol, 2012;3 : 49.

8. Savan R. Post-transcriptional regulation of interferons and their signaling pathways. Journal of Interferon & Cytokine Research, 2014;34(5):318–329.

9. Forster SC, Tate MD, Hertzog PJ. MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response. Frontiers in immunology, 2015;6.

10. David M. Interferons and microRNAs. Journal of Interferon & Cytokine Research, 2010;30(11):825–828.

11. Papadopoulou AS, Dooley J, Linterman MA, Pierson W, Ucar O, Kyewski B, et al. The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-alpha receptor. Nat Immunol, 2011;13(2):181–187.

12. Rath S, Donovan J, Whitney G, Chitrakar A, Wang W, Korennykh A. Human RNase L tunes gene expression by selectively destabilizing the microRNA-regulated transcriptome. Proceedings of the National Academy of Sciences, 2015;112(52):15916–15921.

13. Drappier M, Michiels T. Inhibition of the OAS/RNase L pathway by viruses. Current opinion in virology, 2015;15 : 19–26.

14. Malathi K, Dong B, Gale M, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature, 2007;448(7155):816–819.

15. Nilsen TW, Baglioni C. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proceedings of the National Academy of Sciences, 1979;76(6):2600–2604.

16. Takeda T, Tanabe H. Lifespan and reproduction in brain-specific miR-29-knockdown mouse. Biochem Biophys Res Commun, 2016;471(4):454–458.

17. Song H, Ding L, Zhang S, Wang W. MiR-29 family members interact with SPARC to regulate glucose metabolism. Biochem Biophys Res Commun, 2018;497(2):667–674.

18. Yu D, Green B, Tolleson WH, Jin Y, Mei N, Guo Y, et al. MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells. Biochemical pharmacology, 2015;98(1):215–223.

19. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochemical and Biophysical Research Communications, 2011;412(1):74–79.

20. Guo J, Lin Q, Shao Y, Rong L, Zhang D. miR-29b promotes skin wound healing and reduces excessive scar formation by inhibition of the TGF-β1/Smad/CTGF signaling pathway. Canadian Journal of Physiology and Pharmacology, 2016;95(4):437–442.

21. Park SY, Lee JH, Ha M, Nam JW, Kim VN. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol, 2009;16(1):23–29.

22. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. elife, 2015;4:e05005.

23. Chou CH, Shrestha S, Yang C-D, Chang NW, Lin YL, Liao KW, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic acids research, 2017;46(D1):D296–D302.

24. Rao DD, Vorhies JS, Senzer N, Nemunaitis J. siRNA vs. shRNA: Similarities and differences. Advanced Drug Delivery Reviews, 2009;61(9):746–759.

25. Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Research, 2018;47(D1):D155–D62.

26. Lorenz R, Bernhart SH, Zu Siederdissen CH, Tafer H, Flamm C, Stadler PF, et al. ViennaRNA Package 2.0. Algorithms for Molecular Biology, 2011;6(1):26.

27. Berkner KL, Folk WR. Polynucleotide kinase exchange reaction: quantitave assay for restriction endonuclease-generated 5’-phosphoroyl termini in DNA. Journal of Biological Chemistry, 1977;252(10):3176–3184.

28. Díaz-Guerra M, Rivas C, Esteban M. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology, 1997;227(1):220–228.

29. Nilsen T, Maroney P, Baglioni C. Synthesis of (2’-5’) oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. Journal of virology. 1982;42(3):1039–1045.

30. Li XL, Blackford JA, Hassel BA. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. Journal of virology, 1998;72(4):2752–2759.

31. Chakrabarti A, Ghosh PK, Banerjee S, Gaughan C, Silverman RH. RNase L Triggers Autophagy in Response to Viral Infections. Journal of Virology, 2012;86(20):11311–11321.

32. Al-Ahmadi W, Al-Haj L, Al-Mohanna F, Silverman R, Khabar K. RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. Oncogene, 2009;28(15):1782.

33. Brennan-Laun SE, Li X-L, Ezelle HJ, Venkataraman T, Blackshear PJ, Wilson GM, et al. RNase-L Attenuates Mitogen-stimulated Gene Expression via Transcriptional and Post-transcriptional Mechanisms to Limit the Proliferative Response. Journal of Biological Chemistry, 2014:jbc. M114. 589556.

34. Cooper DA, Jha BK, Silverman RH, Hesselberth JR, Barton DJ. Ribonuclease L and metal-ion–independent endoribonuclease cleavage sites in host and viral RNAs. Nucleic acids research, 2014;42(8):5202–5216.

35. Lee TY, Ezelle HJ, Venkataraman T, Lapidus RG, Scheibner KA, Hassel BA. Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia. Journal of Interferon & Cytokine Research, 2013;33(1):34–42.

36. Hassel B, Hsi T, Ezelle H, Scheibner K. P140 MicroRNA-29 regulation of RNase-L reveals a novel function in oncogenesis. Cytokine, 2012;59(3):565.

37. Li JW, He SY, Feng ZZ, Zhao L, Jia WK, Liu P, et al. MicroRNA--146b inhibition augments hypoxia-induced cardiomyocyte apoptosis. Molecular medicine reports, 2015;12(5):6903–6910.

Štítky
Hygiena a epidemiologie Infekční lékařství Mikrobiologie

Článek vyšel v časopise

Epidemiologie, mikrobiologie, imunologie

Číslo 3

2020 Číslo 3
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Mepolizumab v reálné klinické praxi kurz
Mepolizumab v reálné klinické praxi
nový kurz
Autoři: MUDr. Eva Voláková, Ph.D.

BONE ACADEMY 2025
Autoři: prof. MUDr. Pavel Horák, CSc., doc. MUDr. Ludmila Brunerová, Ph.D., doc. MUDr. Václav Vyskočil, Ph.D., prim. MUDr. Richard Pikner, Ph.D., MUDr. Olga Růžičková, MUDr. Jan Rosa, prof. MUDr. Vladimír Palička, CSc., Dr.h.c.

Cesta pacienta nejen s SMA do nervosvalového centra
Autoři: MUDr. Jana Junkerová, MUDr. Lenka Juříková

Svět praktické medicíny 2/2025 (znalostní test z časopisu)

Eozinofilní zánět a remodelace
Autoři: MUDr. Lucie Heribanová

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#